Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. King, A. Sifrim, Tomas Fitzgerald, R. Rahbari, E. Hobson, T. Homfray, S. Mansour, S. Mehta, Mohammed Shehla, S. Tomkins, P. Vasudevan, M. Hurles (2016)
Detection of structural mosaicism from targeted and whole-genome sequencing dataGenome Research, 27
G. Koumbaris, Elena Kypri, K. Tsangaras, A. Achilleos, Petros Mina, M. Neofytou, V. Velissariou, G. Christopoulou, I. Kallikas, A. González-Liñán, E. Benušienė, A. Latos-Bieleńska, Pietryga Marek, A. Santana, N. Nagy, M. Széll, P. Laudański, E. Papageorgiou, M. Ioannides, P. Patsalis (2016)
Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex.Clinical chemistry, 62 6
Niklas Krumm, Peter Sudmant, Arthur Ko, B. O’Roak, M. Malig, Bradley Coe, A. Quinlan, D. Nickerson, E. Eichler (2012)
Copy number variation detection and genotyping from exome sequence dataGenome Research, 22
F. Fiorentino, S. Bono, Francesca Pizzuti, M. Mariano, Arianna Polverari, Sara Duca, M. Sessa, M. Baldi, L. Diano, F. Spinella (2016)
The importance of determining the limit of detection of non‐invasive prenatal testing methodsPrenatal Diagnosis, 36
R. Stokowski, E. Wang, K. White, A. Batey, B. Jacobsson, H. Brar, Madhumitha Balanarasimha, D. Hollemon, A. Sparks, K. Nicolaides, T. Musci (2015)
Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studiesPrenatal Diagnosis, 35
N. Spinner, L. Conlin (2014)
Mosaicism and clinical geneticsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 166
Darine Villela, S. Costa, A. Vianna-Morgante, A. Krepischi, C. Rosenberg (2017)
Efficient detection of chromosome imbalances and single nucleotide variants using targeted sequencing in the clinical setting.European journal of medical genetics, 60 12
L. Biesecker, N. Spinner (2013)
A genomic view of mosaicism and human diseaseNature Reviews Genetics, 14
T. Rodrigues, Felipe Fidalgo, C. Costa, E. Ferreira, I. Cunha, D. Carraro, A. Krepischi, C. Rosenberg (2014)
Upregulated genes at 2q24 gains as candidate oncogenes in hepatoblastomas.Future oncology, 10 15
L. Conlin, B. Thiel, C. Bonnemann, L. Medne, L. Ernst, E. Zackai, M. Deardorff, I. Krantz, H. Hakonarson, N. Spinner (2010)
Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis.Human molecular genetics, 19 7
F. Lucas, S. Sivakumar, Selina Vattathil, J. Fowler, E. Vilar, P. Scheet (2016)
Rapid and powerful detection of subtle allelic imbalance from exome sequencing data with hapLOHseqBioinformatics, 32
M. Lindhurst, Julie Sapp, J. Teer, J. Johnston, E. Finn, K. Peters, Joyce Turner, J. Cannons, D. Bick, L. Blakemore, Catherine Blumhorst, K. Brockmann, P. Calder, Natasha Cherman, M. Deardorff, D. Everman, Gretchen Golas, R. Greenstein, B. Kato, K. Keppler-Noreuil, S. Kuznetsov, R. Miyamoto, K. Newman, D. Ng, Kevin O'Brien, S. Rothenberg, D. Schwartzentruber, V. Singhal, R. Tirabosco, J. Upton, S. Wientroub, E. Zackai, Kimberly Hoag, Tracey Whitewood-Neal, P. Robey, P. Schwartzberg, T. Darling, L. Tosi, J. Mullikin, L. Biesecker (2011)
A mosaic activating mutation in AKT1 associated with the Proteus syndrome.The New England journal of medicine, 365 7
(2021)
Detection of mosaicism for segmental and whole chromosome imbalances by targeted sequencing
Mosaic segmental and whole chromosome copy number alterations are postzygotic variations known to be associated with several disorders. We have previously presented an efficient targeted sequencing approach to simultaneously detect point mutations and copy number variations (CNVs). In this study, we evaluated the efficiency of this approach to detect mosaic CNVs, using seven postnatal and 19 tumor samples, previously characterized by chromosomal microarray analyses (CMA). These samples harbored a total of 28 genomic imbalances ranging in size from 0.68 to 171 Mb, and present in 10–80% of the cells. All CNV regions covered by the platform were correctly identified in postnatal samples, and only seven out of 19 CNVs from tumor samples were not identified either because of a lack of target probes in the affected genomic regions or an absence of minimum reads for an alteration call. These results demonstrate that, in a research setting, this is a robust approach for detecting mosaicism in cases of segmental and whole chromosome alterations. Although the current sequencing platform presented a resolution similar to genomic microarrays, it is still necessary to further validate this approach in a clinical setting in order to replace CMA and sequencing analyses by a single test.
Annals of Human Genetics – Wiley
Published: Jan 1, 2021
Keywords: ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.